China Universal Asset Management Company’s Procept Biorobotics PRCT Stock Holding History

China Universal Asset Management Company’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$113K	Hold	5,000	–	–	0.01%	405
2026 Q1	$125K	Hold	5,000	–	–	0.01%	390
2025 Q4	$157K	Sell	5,000 -3,000	-38%	-$99.5K	0.01%	368
2025 Q3	$286K	Sell	8,000 -2,000	-20%	-$91.3K	0.02%	300
2025 Q2	$576K	Buy	+10,000	New	+$565K	0.05%	230

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

China Universal Asset Management Company's PRCT Position: Q2 2026 in Review

China Universal Asset Management Company held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 5,000 shares worth $113K. The position accounts for 0.01% of the portfolio, ranked #405.

China Universal Asset Management Company first reported a position in PRCT in Q2 2025 and has held it in 5 quarters since. The position peaked at $576K in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

China Universal Asset Management Company held 5,000 shares of Procept Biorobotics worth $113K as of Q2 2026.
China Universal Asset Management Company left its Procept Biorobotics share count unchanged in Q2 2026.
Procept Biorobotics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #405 holding.
China Universal Asset Management Company first reported a position in Procept Biorobotics in Q2 2025 and has held it in 5 quarters since.
China Universal Asset Management Company's Procept Biorobotics position peaked at $576K in Q2 2025.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.